Exosome Sciences Announces the Publication of Preliminary Findings of a Blood Test to Detect Chronic Traumatic Encephalopathy (CTE) During Life

SAN DIEGO, CA, February 25, 2016 – Exosome Sciences, Inc., in collaboration with majority shareholder Aethlon Medical, Inc. (Nasdaq:AEMD) and investigators at Boston University and the University of Washington, announced today the published preliminary results of possibly the first blood test to detect the neurodegenerative disease, Chronic Traumatic Encephalopathy (CTE) during life. An early online version of these findings has been published in the Journal of Alzheimer's Disease. CTE is associated with exposure to repetitive head impacts, such as those experienced by American football players, and can only be diagnosed post-mortem at this time.

Read more: Aethlon Medical ( AEMD )

Investor Ideas Announces New Business and Financial TV Channel; Wine Down Wednesday

It's not Khloé Kardashian's new Talk Show Kocktails with Khloé – 'The Happiest Hour on TV, it’s Wine Down Wednesday with Investorideas.com  

February 24, 2016 Vancouver BC, Point Roberts WA -  Investorideas.com a  digital global news source covering leading sectors including tech stocks, biotech, mining, energy and renewable energy announces a new business and financial video channel to feature leading experts and management of publicly traded companies; Wine Down Wednesday. The new show is expected to launch in late March.

This new format was created to be relaxing for both guests and listeners; sitting down with a glass of wine after the stock market closes. There is a Vancouver Edition and a North American Edition; to be shot on location in some of the best hotels, restaurants   and wine bars in each city.

Read more: Investor Ideas Announces New Business and Financial TV Channel; Wine Down Wednesday

Announces New WorldVentures DreamTrips SmartCards to Be Delivered in 2016; Purchase Order Valued Up to $15 Million

Melbourne FL, February 22, 2016 -- NXT-ID, Inc. (NASDAQ: NXTD) ("NXT-ID" or the "Company"), a company focused on the growing mobile commerce market, announces the first purchase order for a new SmartCard being developed for WorldVentures vacation club Members. On February 9, 2016, the Company announced that both companies signed off on the hardware specifications for the new product and that it was entering the manufacturing phase.

The DreamTrips™ card is a totally new product for NXT-ID and WorldVentures and will make travel, vacationing and even daily purchases simpler and more secure with a number of new and unique features to be announced prior to launch.

It is a next generation SmartCard that does not require a Wocket® and can operate as a stand-alone device. It can also sync to the DreamTrips Smartphone app for a connected user experience.

Read more: NXT-ID ( NXTD )

Corporate Update; Licensed Mannin Research Glaucoma Technology Advancing on Schedule

NEW YORK, NY – February 17, 2016 - Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company recently provided the following update on recent corporate developments.

Over the last 3 months we have significantly increased our cash position through several convertible note and securities purchase agreements exceeding $1,000,000. As a result, we have positioned ourselves to execute on the initial commitments under our Mannin Research Inc. license agreement and expect that development to continue on schedule.

Mannin's leading technology platform, MAN-01, is moving forward as planned with molecule optimization and the asset development program is being finalized.

Mannin has also been accepted as one of three companies to the Chicago-Canada Mentorship Program (C2MP).

Read more: QBioMed Inc ( QBIO )

Q BioMed Inc. (OTCQB:QBIO) To Present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at the Ritz in South Beach on Feb. 22, 2016

New York, NY – (February 16, 2016) – Q BioMed Inc. (OTCQB: QBIO) a biotechnology acceleration company, today announced that the company will present at the SeeThruEquity & The Brewer Group 2nd Annual Innovations Investor Conference at The Ritz-Carlton in Miami on South Beach on February 22, 2016.

Please click here for a list of presenting companies.

Each company will be provided with a 30-minute time slot to present to an audience of investors and industry professionals and company management will also be available for one-on-one meetings with institutional investors.

Conference registration: complimentary for qualified investors and equity research analysts.

Read more: Q BioMed Inc ( QBIO )